Angelini Tantum Verde Gola Spray 0.25% Solution For Oral Mucosa 15ml

TANTUM VERDE THROAT NEBULIZER 0.25% 15 ML

Indications

Symptomatic treatment of irritative-inflammatory states, also associated with pain in the oropharyngeal cavity (eg pharyngitis, gingivitis, stomatitis), also as a consequence of conservative or extractive dental therapy.

Contraindications

Hypersensitivity '(asthma, urticaria or allergic type) towards flurbiprofen or to any of the excipients and towards aspirin or other NSAIDs. In the third trimester of pregnancy. Patients who have or have had a peptic ulcer in the past.

Dosage

Undesirable effects can be minimized by using the lowest effective dose for the shortest possible duration of treatment needed to control symptoms. >> Mouthwash: 2-3 rinses or gargles a day with 10 ml of mouthwash. It can be diluted in water. Pour 10 ml of mouthwash into the measuring cup to be used in pure form, as a gargle, or in diluted form, as an oral rinse, adding water to the cup itself. >> Solution: 2 sprays 3 times a day addressed directly to the affected area. Each spray delivers 0.2 ml of solution equivalent to 0.5 mg of active ingredient. Use the drug as needed, at any time of the day.

Warnings

At the recommended doses, any occasional swallowing of the product does not cause any harm to the patient as these doses are much lower than those commonly used in treatments with systemic flurbiprofen. Use with caution by patients with non-allergic asthma, in fact there have been reports of bronchospasm with flurbiprofen in patients with a history of bronchial asthma. Its use, especially if prolonged, can give rise to sensitization or local irritation phenomena. In such cases, treatment should be discontinued and appropriate therapy instituted if necessary. Do not use for prolonged treatments. The use of medicines containing ethyl alcohol can determine positive doping tests in relation to the alcohol concentration limits indicated by some sports federations.

Interactions

There are no known interactions with other drugs or otherwise.

Side effects

The use, especially if prolonged, can give rise to sensitization and local irritation phenomena, in which case it is necessary to interrupt the treatment and institute, if necessary, a suitable therapy. These phenomena are generally transient. Disorders of the blood and lymphatic system: thrombocytopenia, aplastic anemia and agranulocytosis. Immune system disorders: anaphylaxis, angioedema, allergic reaction. Nervous system disorders: dizziness, cerebrovascular accidents, visual disturbances, optic neuritis, migraine, paraesthesia, depression, confusion, hallucination, dizziness, discomfort, fatigue and somnolence. Acoustic and labyrinth disorders: tinnitus. Respiratory, thoracic and mediastinal disorders: reactivity of the respiratory tract (asthma, bronchospasm and dyspnoea). Gastrointestinal disorders: nausea, vomiting, diarrhea, flatulence, constipation, dyspepsia, abdominal pain, melaena, haematemesis, ulcerative stomatitis, gastrointestinal haemorrhage and exacerbation of colitis and Crohn's disease. Gastritis, peptic ulcer, perforation and ulcer haemorrhage were observed less frequently. Skin and subcutaneous tissue disorders: rash, pruritus, urticaria, purpura and very rarely bullous dermatosis (including Stevens-Johnson syndrome, toxic epidermal necrolysis and erythema multiforme). Renal and urinary disorders: nephrotoxicity in various forms, including interstitial nephritis and nephrotic syndrome. Rare cases of renal failure have been reported.

Pregnancy

During the first and second trimester of pregnancy, flurbiprofen should not be administered except in strictly necessary cases. However, the administration of flurbiprofen is not recommended in nursing mothers.